loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2012_037___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    PolyPeptide Group

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 POLYPEPTIDE S.A. Braine-L'Alleud BE (1)

    filter

    01 Desmopressin, Liquid phase synthesis process , Process F (1)

    filter

    01 Belgium (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    POLYPEPTIDE S.A. Braine-L'Alleud BE

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Desmopressin, Liquid phase synthesis process , Process ...

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2012-037 - Rev 00
    Withdrawn by Holder
    Chemical
    2017-07-12
    2023-05-15
    712
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2012-037 - Rev 00 of Polypeptide S.a. Braine-l'alleud Be

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2012-037 - Rev 00 of Polypeptide S.a. Braine-l'alleud Be 1

    20

    Polypeptide S.a. Braine-l'alleud Be, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their significant offerings is Desmopressin, Liquid phase synthesis process , Process F, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2012-037 - Rev 00

    This Chemical Type CEP, issued on July 12, 2017, remains in force until May 15, 2023, ensuring its reliability within the pharmaceutical industry.

    Substance Number 712 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY